Molecular Docking Studies on The Anti-Cancer Activity of Novel Tri-Substituted Fluoro Indole Derivatives Against Human Topoisomerase-Ii Enzyme using In-Silico Methods

Authors

  • Sabin Shrestha Department of Pharmacy, Manmohan Memorial Institute of Health Sciences, Soalteemode, Kathmandu, Nepal
  • Dharma Prasad Khanal Department of Pharmacy, Manmohan Memorial Institute of Health Sciences, Soalteemode, Kathmandu, Nepal
  • Pharsuram Adhikari Department of Pharmacy, Manmohan Memorial Institute of Health Sciences, Soalteemode, Kathmandu, Nepal https://orcid.org/0000-0001-6121-3868
  • Rahi Bikram Thapa Department of Pharmacy, Purbanchal University College of Medical and Allied Sciences, Gothgaun, Morang. https://orcid.org/0009-0002-2675-7856
  • Rituparna Maji Department of pharmaceutical chemistry, Nargund college of pharmacy Bengaluru, Karnataka, India

DOI:

https://doi.org/10.3126/jmmihs.v9i1.68639

Keywords:

Indole, Docking, Cancer, Topoisomerase, DNA-gyrase

Abstract

Background: Cancer remains the leading cause of the death worldwide and expected that annual cancer case will rising very rapidly and make the scenario even more troublesome as well as Due to drug resistance makes things even worse.

Method: Auto Dock 4.1 was used to evaluate selected tri-substituted fluoro indole molecules against human topoisomerase II and Discovery studio visualizer and marvin sketch was used to create 3D and 2D structure interaction. Tri-substituted fluoro indole derivatives were docked against the human topoisomerase II enzyme using in-silico methods and various web server was used to determine various parameters.

Results: Docking studies revealed that tri-substituted fluoro indole derivatives could be a good alternate against human topoisomerase II as an anti-cancer agent. Molecular docking score scored by fludarabine [-7.6, -7.6, -8.6, -7.7] kcal/mol with nine hydrogen bonds, S-2 [-8.8, -7.7, -9.6, -8.7] kcal/mol with elveven hydrogen bonds, and S-14 showed [-9.2, -8.2, -8.6, -8.6] kcal/mol with twelve hydrogen bonds respectively in chain-A, B, C, D with excellent drug likeness, good pharmacokinetics parameters, mild toxicity in In-silico model reveals that Tri-substituted fluoro indole derivatives could be a good alternate against human topoisomerase II as an anti-cancer agent.

Conclusion: Among twenty derivatives S-2 and S-14 showed potential inhibitory effect against 4R1F human topoisomerase II with excellent docking score, drug likeness, good pharmacokinetics parameters, mild toxicity in Insilco model.

Downloads

Download data is not yet available.
Abstract
502
PDF
289

Downloads

Published

2024-08-09

How to Cite

Shrestha, S., Khanal, D. P., Adhikari, P., Thapa, R. B., & Maji, R. (2024). Molecular Docking Studies on The Anti-Cancer Activity of Novel Tri-Substituted Fluoro Indole Derivatives Against Human Topoisomerase-Ii Enzyme using In-Silico Methods. Journal of Manmohan Memorial Institute of Health Sciences, 9(1), 35–42. https://doi.org/10.3126/jmmihs.v9i1.68639

Issue

Vol. 9 No. 1 (2024)

Section

Articles

License

Copyright on any research article in JMMIHS is retained by the author(s).
The authors grant JMMIHS a license to publish the article and identify itself as the original publisher.

The corresponding author is responsible for any conflict of interest between authors and others. The journal is not responsible for concepts, ideas, and views reflected in the articles published in the journal. The article will be retracted if any violation of an ethical issue is detected.

The articles in JMMIHS are licensed under a https://creativecommons.org/licenses/by/4.0/  (CC BY).
This license permits use, distribution, and reproduction in any medium, provided the original work is properly cited, and it is not used for commercial purposes.